Synergistic Li/Li Bimetallic System for the Asymmetric Synthesis of Antituberculosis Drug TBAJ-587-Reference-Cited by-同舟云学术

Synergistic Li/Li Bimetallic System for the Asymmetric Synthesis of Antituberculosis Drug TBAJ-587

Published:2023-05-01 Issue:11 Volume:88 Page:7601-7606
ISSN:0022-3263
Container-title:The Journal of Organic Chemistry
language:en
Short-container-title:J. Org. Chem.

Author:

Ahmad Tanveer¹,Gao Feng¹,Li Jing²,Zhang Zhenfeng²^ORCID,Song Tao¹,Yuan Qianjia¹,Zhang Wanbin¹²^ORCID

Affiliation:

1. Frontiers Science Center for Transformative Molecules, School of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, China

2. Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, School of Pharmacy, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai 200240, China

Funder

Shanghai Jiao Tong University

Bill and Melinda Gates Foundation

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.joc.3c00705

Reference50 articles.

1. a The top 10 causes of death. World Health Organization, 2020. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death (accessed 2019-11-11).

2. b Global Tuberculosis Report 2021. World Health Organization, 2021. https://www.who.int/publications/i/item/9789240037021 (accessed 2021-10-14).

3. Discovery of a Novel Mycobacterial F‐ATP Synthase Inhibitor and its Potency in Combination with Diarylquinolines

4. Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts

5. Novel candidates in the clinical development pipeline for TB drug development and their synthetic approaches